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Databasesh i g h l i g h t s
 Standard instrumentation ensures high quality recordings and enables comparison of results.
 This consensus document on ‘‘Standards of Instrumentation of EMG” is written by an expert panel.
 This report covers technical aspects as well as topics for optimal and standardized examinations.
a b s t r a c t
Standardization of Electromyography (EMG) instrumentation is of particular importance to ensure high
quality recordings. This consensus report on ‘‘Standards of Instrumentation of EMG” is an update and
extension of the earlier IFCN Guidelines published in 1999. First, a panel of experts in different fields from
different geographical distributions was invited to submit a section on their particular interest and exper-
tise. Then, the merged document was circulated for comments and edits until a consensus emerged.
The first sections in this document cover technical aspects such as instrumentation, EMG hardware and
software including amplifiers and filters, digital signal analysis and instrumentation settings. Other sec-
tions cover the topics such as temporary storage, trigger and delay line, averaging, electrode types, stim-
ulation techniques for optimal and standardised EMG examinations, and the artefacts
electromyographers may face and safety rules they should follow. Finally, storage of data and databases,
report generators and external communication are summarized.
 2019 The Author(s). Published by Elsevier B.V. on behalf of International Federation of Clinical Neu-
rophysiology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Instrumentation and technical issues play an important role in
an electromyographeŕs daily routine. At one level, everyone is
familiar with artefacts and noise which may distort electrophysio-
logical signals and can resemble results from nerves or muscles.
High quality recordings are essential to the examination. In addi-
tion, it is suggested that increasingly, standardisation of instru-
mentation and recording will enable comparison of
Electromyography (EMG) and nerve conduction studies (NCS)
results within and between laboratories. Such standards and
guidelines will allow a uniform practice and improve the selection
of patients for research studies. Evidence-based documentation is,
at present, sparse in electrodiagnostic medicine (Fuglsang-
Frederiksen and Pugdahl, 2011). Standardisation is becoming more
important in the health care system, with rapidly improving new
technology enabling greater standardisation of instrumentation.
Most EMG equipment is now digital and computer-based.
Reports on electromyographic instrumentation have been pub-
lished previously (Guld et al., 1970; Guld et al., 1974; Guld et al.,
1983; Bischoff et al., 1999). The present consensus report is an
update and extension of the latest report in Recommendations for
the Practice of Clinical Neurophysiology: Guidelines of the Interna-
tional Federation of Clinical Neurophysiology (EEG Suppl. 52)
(Bischoff et al., 1999). In the present report the technical aspects,
i.e. amplifiers, filters and instrumentation have been covered in
detail, much as in the report from 1999. However, these sections
have been updated corresponding to the advanced knowledge in
technology in the recent decades. Similarly, the sections on data-
bases and storage of data, report generation and external commu-
nication have required considerable updating because of
developments in computer science. In the former report, signal
averaging and noise reduction were mentioned briefly, only for
recordings of SNAPs. In the present document we added evokedpotentials, EMG and EEG signals, as well as some practical aspects.
In the previous document, the safety section was only mentioned
briefly and was limited to electrical safety. In the present report
we now also discuss the safety issues of implanted pacemakers,
cardiac defibrillators and stimulators and classical and novel anti-
coagulants in the light of the recent literature.
This report addresses instrumentation for common diagnostic
tests – e.g., EMG, nerve conduction, evoked potentials. It was not
intended to be a comprehensive review of techniques for which
the instrumentation is used, but of necessity aspects of some tech-
niques are considered, focusing on procedures of established clin-
ical value. We therefore mention some of the tests in more detail
and in the relevant sections some new developments in neuro-
physiology have also been covered.
There have been considerable developments not only in the
technological improvement of EMG equipment, but also in imaging
methods and genetics. EMG remains the primary and most com-
monly used method in routine clinical practice, even in developed
countries, but imaging and genetics can provide complementary
data. Among the imaging methods, ultrasonography has gained
an established place in EMG laboratories supplementing electro-
physiological studies.
For the generation of this consensus document, a panel of
experts, in different fields and from different geographical regions,
was invited to submit a section on their particular interest and
expertise. Then, the merged document was circulated for com-
ments and edits until this consensus was achieved. This report
does not present clinical practice guidelines, and a search strategy
in e.g. PubMed was not appropriate for this topic.
2. Instrumentation
Contemporary EMG machines have a dedicated hardware unit
with amplifiers, stimulators, control panel and a separate com-
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replaced, while keeping the EMG hardware unit. In the EMG hard-
ware, the amplifiers and stimulators are the most important parts.
Some hardware includes an ultrasound facility. Often ignored, but
an important aspect of any machine is its ergonomics and control
panel functions, including the foot switch and hand controls.
When setting up a machine, it should be tuned optimally,
preferably by a team including representatives from the users
(physicians, technicians, local engineers) and manufacturers.
When considering which machine to purchase, these details must
be considered, since they influence medical quality, operability
and, in the long term, cost efficiency.
Computer hardware
(A) Number of screens: Multiple screens allow EMG signals and
data to be shown simultaneously with other data, such as
the referral or radiology.
(B) CPU speed and RAM memory size: The minimum limits are
specified by the EMG equipment manufacturer. The require-
ments depend on the complexity of software.
(C) Hard drive size: The minimum limits are specified by the
EMG equipment manufacturer. If data is to be stored locally,
the minimum size needs to be sufficient for the estimated
number of stored patients. Greater memory is usually
needed at some time, so anticipation of this is
recommended.
(D) Loudspeaker for replay of EMG signals without EMG hard-
ware unit. A good sound quality is essential.
(E) Printer: Local and/or network connected.
Software
(A) Analysis software
(a) Available tests, workflow and various other features
should optimize workflow and be compatible with local
practice and reference limits.
(b) Help function such as strategies and signal quality
control.
(c) Reference limits
& Prepare for ongoing collection of reference material
& Result presentation; Tables, signals, text, color
& Compatibility with used algorithms(d) Voice control may be used for some functions
(B) Remote viewer: View ongoing (live) recordings remotely
from another computer.Fig. 1. The organization of various components and accessorie(C) Database support: Ensure the database engine used by the
EMG equipment is supported and compatible with the ser-
ver to be used.
(D) Operating system
The type and version options are specified by the EMG equip-
ment manufacturer.
(E) Reportings to an e(a) Multiple designable templates that comply with require-
ments from all referring sources.
(b) Digital delivery of text, signals, tables2.1. EMG hardware and software
The primary function of the electrodiagnostic system is to faith-
fully record and analyse various biological signals. It is important
to have an optimal ‘signal to noise ratio’, i.e. amplify the neuro-
physiological signal voltage while attenuating background noise.
This is done using analogue hardware and digital signal processing
techniques (Fig. 1).
The signal and noise are recorded by surface or needle elec-
trodes. It is carried to the amplifier input via electrode leads or
cable. These components behave like an antenna and may add
more noise. A differential amplifier magnifies the signal while
attenuating the unwanted noise, aided by analogue filters. The
amplified signal is measured using an analogue-to-digital conver-
tor (ADC) and the voltage values stored as an array of numbers.
This digitised signal allows further computerized analysis.
Some algorithms reduce the noise, e.g., digital filters, averaging,
smoothing, etc., and others make measurements such as latency,
amplitude and area in NCS. More sophisticated algorithms can
detect MUPs in needle EMG. Signal characteristics are also assessed
from the signal sound, generated either with analogue hardware or
using the digital technology.
An EMG machine also offers stimulation devices to excite
nerves and muscles. These may generate electrical, visual or audi-
tory stimuli. External devices providing other forms of stimulation,
e.g. magnetic field, contact heat, reflex hammer, etc. can be inter-
faced to provide timing signals through so-called ‘triggers’. To
achieve this, some instruments pass the digitized signals through
a ‘digital-to-analogue convertor (DAC)’, to convert digital signals
(with much less noise) into analogue form. This can be used for
research where the investigator wants to re-sample the signals
and develop algorithms for their own analysis.lectrodiagnostic system are shown schematically.
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tings of the amplifier and stimulator. The latter can be changed
using a dedicated control panel or using software commands via
a mouse or computer keyboard. Data collection can be initiated
using the foot switch.
The software is responsible for signal processing and for generat-
ing reports. Databases can be created, and remote review used for
second opinions or to help with interpretation.
Constant changes in operating systems and in regulations governing
patient information protection can make this a challenging task.
The electrodiagnostic systems can also record non-
neurophysiological events. Temperature, for instance, should be
measured and recorded during NCS. A ‘patient response’ unit
may be used to record the number of times the test subject
acknowledges different types of stimuli in cognitive function
assessments. Video cameras may be integrated into the system
to observe the patient’s behaviour during a study, e.g., focusing
on the checkerboard pattern in a visual evoked potential investiga-
tion. Recently we have seen the addition of ultrasound imaging
probes to the device. The handling of these inputs is very different
from that of the neurophysiological potentials, and is outside the
scope of the current discussion.
2.1.1. Amplifiers
The amplifier is perhaps the most critical component for the
quality of the electrodiagnostic system. Selective amplification of
a neurophysiological potential while attenuating background noise
can be accomplished using a ‘differential’ amplifier (DA) (Webster,
1998). DA requires inputs or connections from three electrodes
(Fig. 2).
In past the electrodes were called ‘G10, ‘G20 and ‘ground’. The
termsG1andG2refer to thegridsof vacuumtubesused inold ampli-
fiers which are no longer available. Later these inputs were called
‘active’, ‘reference’ and ‘ground’. The term ‘ground’ is confusing.
The ‘ground’ in electrodiagnostic recording refers to a point on the
amplifier circuit that is used as a point of reference for voltagemea-
surement. Outside electrodiagnostics, it is also used to describe one
of the connections in the power supply and wall outlets. The ‘refer-
ence’ electrode is presumed to be electrically silent but does record
large volume-conducted potentials, such as the electrocardiogram
(ECG). Given the confusion of terms and their origins, the terms
‘E10, ‘E20 and ‘E00 are recommended for the three connections to
the amplifier (Robinson et al., 2016). On most systems these inputs
are colour-coded as black (E1), red (E2) and green (E0).Fig. 2. The operation of the differential amplifier is illustrated. (A) Differential signal inpu
amplitude, N: Noise amplitude).The amplifier does not amplify the voltage at E1 or E2 inputs. It
magnifies their difference, and hence it is called a differential
amplifier. Fig. 2A shows the E1 electrode (a monopolar needle)
recording a 50-lV fibrillation potential. The E2 is a surface elec-
trode placed on the skin surface and for simplicity it is assumed
that it records no electrical activity, i.e. 0 lV. Their difference is
amplified and the fibrillation potential is seen as a 50,000 lV sig-
nal. This amplification by 1,000 is the ‘differential’ gain of the
amplifier. The ambient noise is also recorded by both electrodes
and their cables. Here the ‘common’ noise is 1,000 lV, but the dif-
ference between signals at E1 and E2 is zero, and the noise will not
be seen at the amplifier output. Similarly, the very large ECG
potential can be eliminated by differential amplification. This
enables the selective amplification of the small neurophysiologic
signal in the presence of high-amplitude noise. The example
reflects an ‘ideal’ DA. In practice the ‘common signal’ at E1 and
E2 inputs is also amplified, but much less. In Fig. 2B, the noise volt-
age at the output is 500 lV. The ratio of output to input noise volt-
age, produces a ‘common mode gain’ of 0.5 for the amplifier.
In this example, the signal-to-noise ratio at the amplifier input
is 0.05 and would make it difficult to recognize the fibrillation
potential. However, at the output of the amplifier the signal-to-
noise ratio is 100, and this would allow it to be recognized quite
easily. A DA should have a high differential gain and low common
mode gain. These properties are defined in a single characteristic
called the common mode rejection ratio (CMRR). It is reported in
units of decibels and calculated as
CMRR ðdBÞ ¼ 20 Log ðDifferential Gain=Common mode gainÞ
In our schematic amplifier, the CMRR is 66 dB. Modern electro-
diagnostic systems have amplifiers with CMRR exceeding 100 dB.
It is important to note that the CMRR decreases at higher frequen-
cies. Most vendors specify the value at 50 or 60 Hz (i.e., power line
frequency).
Another characteristic of the amplifier is the input voltage
range. As example, if the range is 50 to + 50 lV, then signals with
amplitudes between these ranges can be handled without distor-
tion. If the signal amplitude is outside the range, it will saturate
the amplifier and the true signal amplitude cannot be measured.
This is recognized from the ‘clipped’ peaks of the signals on the dis-
play. So, the amplifier range should be set higher than the ampli-
tude of signals recorded in the test. In sensory NCS, the stimulus
artefact can be much bigger than the nerve response. If thets are amplified. (B) The common signals (here noise in B) are attenuated. (S: Signal
H. Tankisi et al. / Clinical Neurophysiology 131 (2020) 243–258 247amplifier saturates, it can generate a long duration artefact that
interferes with the sensory potential to be recorded. The range is
controlled in the software to avoid such distortion.
The electronic components of the amplifier also produce some
noise This is addressed by the E1, E2 and E0 electrodes being con-
nected together and the amplifier output measured. The peak-peak
amplitude or root mean square (RMS) value of the signal are
reported. RMS is usually less than 1 lV, but also depends on the
amplifier range and the filter settings. High amplifier range (i.e.
low gain setting) and short band width will give lower noise.
The amplifier is also characterized by its ‘input impedance’. As
the amplifier needs a tiny amount of current to measure a voltage,
the input impedance needs to be several orders of magnitude lar-
ger than the input impedance of the generator of the voltage, i.e.
muscle, nerve, body fluids. Essentially, the voltage measured
(Vm) is given by: Vm = Vsource*(Ropamp)/(Rsource + Ropamp).
With Rsource the ‘internal impedance’ is meant. If Ropamp =
Rsource, then Vm = 0.5*Vsource. Without going into details of cir-
cuit analysis, the amplifier impedance should be high. Low impe-
dance makes the system more sensitive to environmental noise.
It may also underestimate signal amplitude. Fortunately, modern
systems report impedances in excess of 100 to 1000 mega-X. Just
like CMRR, the impedance decreases at higher frequencies.
Modern systems offer ‘switching amplifiers’. The unit provides a
‘head box’ with many input connections. The user can select the
inputs in software to select any pair of inputs to make a recording.
This facility is used mainly for evoked potential studies where a
small set of electrodes is used to create multiple channels of
recordings. These channels usually have a much lower CMRR. Such
channels may not be suitable for recording signals with high fre-
quencies (e.g., needle EMG) or when the electrodes differ in their
impedances (surface versus needle). To facilitate appropriate set-
tings of the amplifier, the signals characteristics of different test
procedures are summarized in Table 1.
The best strategy for high quality recordings is to reduce the
ambient noise and to ensure that the noise is not different on E1
and E2 electrodes.2.1.2. Filters
Ideally, our measurement system should reproduce the signal of
interest as exactly as possible while rejecting undesired signals. InTable 1
Typical signal amplitudes, filter settings and sampling frequency, fs (Nilsson et al.,
1993) in different electrodiagnostic test procedures. Filter settings are defined by the









0–50 mV 1 Hz–5 kHz 20
Sensory nerve action
potential
0–100 uV 10 Hz–5 kHz 20
Needle EMG 0–30 mV 2 Hz–10 kHz 50
Single fibre EMG 0–50 mV 500 Hz–10 kHz 50
Surface EMG 0–10 mV 1 Hz–1 kHz 5
Somatosensory evoked
potentials
0–50 lV 30–3000 Hz 20
Visual evoked potential 0–0.5 mV 1–100 Hz 1
Auditory evoked potentials 0–50 lV 100 Hz–3 kHz 10
Cognitive evoked potentials 0–50 lV 0.1–200 Hz 1
Sympathetic skin response 0–2 mV 0.1–100 Hz 1
Electrocardiogram1 0–5 mV 10–100 Hz 2
Electroencephalogram 0–300 lV 1–200 Hz 500 Hz
1 For heart rate variability studies.
2 Peak to peak signal amplitude also includes the background signal level.clinical practice, however, we typically obtain a mixture of signals
and ‘noise’, where the latter refers to any signal that does not con-
tain relevant information for our diagnostic procedure. The unde-
sired signal components can result from ambient power line
noise (50 Hz or 60 Hz) or movement artefacts, but can also include
EMG signals in a frequency range that is outside the region of inter-
est for a particular procedure. For example, in recording single-
fibre action potentials, the signal of interest is in the frequency
range 0.5–5 kHz, where lower-frequency components (such as dis-
tant EMG potentials) can be safely suppressed. While filtering
refers to any process where irrelevant signals are suppressed, in
most clinical situations filtering is limited to attenuation of partic-
ular frequency components in the signal. The name of a filter is
then defined by the frequency values that the filter attenuates
(low or high frequency filters) or passes (high-pass filter, band-
pass filter). The amount of attenuation depends on the ‘‘steepness”
of the filter (expressed as the attenuation in dB/octave) and the
cut-off frequency. The cut-off frequency is defined as the frequency
where the original signal’s amplitude is attenuated by 3 dB. In
today’s equipment, all filters (except for the anti-aliasing filter)
are digital, which also allow filtering of frequency components
with minimal phase distortion of the signals. We will discuss the
most common frequency filters.
Low-frequency filters (LFF; high pass filters)
Low-frequency (or, synonymously, high-pass) filters attenuate
low frequency components in the signal. An increase in the low-
frequency cut-off causes initial amplitude loss of slowly changing
signals, waveform distortion, but more importantly it also
decreases the latency to the peak of the waveform and can intro-
duce artefacts (i.e. a tail of the motor unit action potential). When
recording motor unit potentials (MUP), the duration as well as the
amplitude decreases when the cut-off is increased up to 500 Hz.
Using a 500 Hz cut-off the contribution from distant muscle fibres
is attenuated because of the soft tissue itself acts as a high-
frequency filter. Ideally the low limiting frequency should be one
decade (factor 10) lower than the lowest frequency of the signal,
to make sure that a phase shift, if present at all, does not affect
latencies. Movement artefacts contain slow frequencies. In some
cases, the only way to remove this artefact is to increase the lower
limiting frequency. This is commonly done for surface EMG record-
ing of movements (e.g., tremor recordings; gait) and may be neces-
sary for motor evoked potential recordings to transcranial
magnetic stimulation (TMS). It is usually required if EMG traces
are rectified before averaging, e.g., for averaged F waves.
High-frequency filters (HFF; low pass filters)
High-frequency filters attenuate high frequencies. A decrease in
the high-frequency cut-off reduces the amplitude and rise time. If
using a high-frequency cut-off that is too low, the system will not
be able to record adequately the rise of the potential (containing
the highest frequencies of the signal), and this may (i) lower the
amplitude, (ii) reduce the number of phases and (iii) prolong the
duration of the main peak component of the signal. An inappropri-
ate HFF can also affect the measurement of onset latency of a
potential. It will be prolonged because the abrupt decline from
the baseline is missed and more time elapses before the beginning
of the potential can be appreciated.
Band-pass filters
Most filters used are band-pass filters, a combination of a high
and low frequency filter. The effects of changing the frequency
range of a bandpass filter on recording a MUP is illustrated in Fig. 3.
Notch filter
A notch filter is a special type of band stop filter. In electrophys-
iology it is normally designed to reduce power line interference
(50 Hz or 60 Hz). Ideally, it should not be used because most neu-
rophysiological signals contain significant components at this fre-
quency, and their use may hide interesting components. In
Fig. 3. Effect of different bandwidths of band-pass filters on shape, amplitude and duration of a motor unit action potential. From Bischoff et al., Standards of instrumentation
of EMG, 1999.
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notch frequency, and this may distort the waveform.3. Digital instrumentation
EMG equipment uses digital computers for data sampling, stor-
age and signal processing. After the analogue signal has been
amplified, the analogue-to-digital (AD) converter discretizes the
signal in both time and amplitude, and assigns a digital value to
the amplitude at defined time points. This assignment of the
amplitude to a digital value is performed by using a finite number
of digital amplitude values. In this conversion process, two impor-
tant criteria must be satisfied. First, the sampling frequency should
be sufficiently high to reliably represent the original analogue sig-
nal. Second, the digitization of the amplitude should be sufficiently
fine to accurately represent the amplitude of the original signal in
the digital domain. These two constraints are illustrated in Fig. 4,
digitizing an analogue signal, consisting of a sine wave with fre-
quency 1 Hz and amplitude 1 mV using different sampling rates
and AD converters. The phenomenon illustrated in Fig. 4, panel B
is known as ‘‘aliasing”: if the sampling frequency, fs, is lower than
the highest frequency present in the signal of interest, fmax, the
frequency obtained has an erroneous value, in this example
0.1 Hz. Using appropriate algorithms, it is possible to reconstruct
the waveform in detail if the sampling rate is more than twice
the highest-frequency component of the waveform (Nyquist theo-
rem). In practice, the sampling frequency used is typically 2–5
times the highest frequency component in the signal of interest.
In order to guarantee that the maximum frequency in the signal
is known, an analogue ‘‘anti-aliasing” filter is used before the signal
is digitized. Table 1 presents typical values. The required number
of bits for the AD converter is defined by the desired amplitude res-
olution and the maximum amplitude of the signal. Current AD con-verters are 24 bits or more, which is more than sufficient for most
applications (van Putten, 2009).4. Digital signal analysis
To complement visual analysis of the EMG, various quantitative
tools can be used. It is noted, however, that an experienced neuro-
physiologist can interpret most findings for clinical diagnostic pur-
poses with careful visual inspection and auditory assessment. For
research purposes, however, quantitative EMG (qEMG) is exten-
sively used. In some laboratories, qEMG is used routinely for clin-
ical purposes.
4.1. Frequency analysis
When the subject is exerting a constant force, the surface EMG
can be used for spectral analysis, creating the power spectrum den-
sity. During continued muscle activity, mean and median frequen-
cies typically decrease. Using needle EMG and constant force,
frequency analysis of MUPs has shown that the frequency distribu-
tion is shifted towards higher frequencies in myopathies and
towards lower values in patients with neurogenic disorders
(Fuglsang-Frederiksen, 2000).
4.2. Turns-amplitude analysis
In this technique, the amplitude of the interference pattern is
plotted versus the number of turns for different levels of contrac-
tion. A ‘‘turn” is defined as a reversal of voltage of > 100 lV, and
if the interference pattern has many turns it will look and sound
spiky. By comparing the distribution with normal values, myo-
pathic and neurogenic patterns can be differentiated (Fuglsang-
Frederiksen et al., 2016).
Fig. 4. Panel A: analog sinus signal with frequency 1 Hz and amplitude 1 mV. Panel B. Sampling with 0.9 Hz results in aliasing, where the resultant analog signal is a sinus of
0.1 Hz. Panel C: sampling at a frequency of 100 Hz, but with a 3 bits AD converter, resulting in 5 digital amplitude values (23-1), as one bit is needed for the sign (positive or
negative) of the signal. This significantly distorts the representation of the signal. Panel D shows the digital signal sampled at 100 Hz with an 8-bit AD-converter, where the
analog signal is now reliably represented in the digital domain. Note the altered time bases, which are not given under A and B.
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The EMG machine setting is one of the important parts for
acquiring data. It should be adjusted to the same setting as those
when control data were collected by the laboratory.
Gain and sweep speed enable display of waveforms on the
screen, and should be adjusted during practice to ensure the wave-
forms display perfectly in the window, avoiding overlap, and of
sufficient size to be viewed and measured clearly (Table 2). The
gain, and to a lesser degree sweep speed, can affect the latency
measurement of action potentials, including distal motor latency,
duration of compound muscle action potential or MUP, etc. As gain
is increased (high sensitivity), it will become apparent that where
the potential really begins (i.e., the onset latency) is less than at
low gain, and the duration will increase. So, when measuring the
latency, the gain and sweep speed should be adjusted to the same
special setting as used when recording normal control values
(Figs. 5 and 6).Table 2
Recommended gain and sweep speed settings for the commonly used electrodiag-
nostic recordings.
Test Gain (mV/division) Sweep speed
(ms/division)




F wave/H reflex studies 200 5–10
Repetitive nerve stimulation 2000 2 or 200
EMG At rest 100 5–10
Minimal contraction 200–1000 5–10
Maximal contraction 1000 100
Single-fibre EMG 200–1000 0.5–1
Sympathetic skin response 500–1000 500–1000In digital EMG machines automatic cursor placement algo-
rithms are available. While these are very useful and provide stan-
dardization for measurements and usually high accuracy, it is
mandatory to inspect visually the accuracy of cursor placement.6. Temporary storage, trigger and delay line
All modern commercially available EMG machines have the
functions of temporary storage, and trigger and delay lines. The lat-
ter allows the isolation of a single action potential from other
action potentials and so enables analysis and confirmation of the
consistency of the shape. By delaying each action potential after
it has triggered the sweep, it appears in the same position on the
screen every time there is a discharge of that unit. This requires
an electronic delay circuit and the temporary storing of the
recorded MUP. The sweep is triggered by the potential in real time,
but the display is delayed by the preset interval (Kimura et al.,
1988; Czekajewski et al., 1969; Nissen-Petersen et al., 1969). With
this arrangement, the potential studied can occur repetitively and
in its entirety in the same spot on the screen for precise measure-
ment of action potential parameters in a short time. Use of a delay
line is essential for the analysis of spontaneous activities, of MUPs
in the concentric needle EMG and of jitter in single fibre EMG.
The trigger can be placed at the different levels on the action
potential to discriminate between different units. When the signal
amplitude is less than the trigger level, the signal is not displayed,
and when the amplitude exceeds the trigger level, the system
acquires and displays one sweep. However, any potentials larger
than the trigger level will trigger the sweep. Some EMG machines
can also acquire the potentials with an amplitude between two
trigger levels (window trigger), thus allowing the clinician to select
a potential that is not the largest. During continuous recordings, a
series of action potentials with the same features will be displayed
Fig. 5. The distal motor latency (DML) increased with increased gain. A. the DML was 2.8 ms when measured at 5 mV/D, B. the DML was 2.6 ms when measured at 0.5 mV/D.
The measurements were done manually.
Fig. 6. The sweep speed should be changed according to different conditions. A. F wave studies recorded at routine sweep speed (5 ms/D) in a patient with Morvan syndrome.
B. when the sweep speed was adjusted to 20 ms/D, the after-discharges were detected.
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tude trigger allows the clinician to see the EMG signal after the
trigger occurs, the delay line allows the clinician to see the activity
that precedes the trigger, and temporary storage allows the signal
display on the screen for a short time for analysis. These functions
are important for observing the repeatability of the potential dur-
ing MUP analysis of needle EMG, and for recording stable single
fibre action potentials for jitter analysis in single fibre EMG.
Another function of the trigger is to initiate the recording of an
action potential. In motor NCS or sympathic skin response, the trig-
ger occurs when the nerve is stimulated. When the computer dis-
plays the signals immediately after triggering, the whole waveform
can be seen on the screen. In sensory NCS or evoked potential stud-
ies, the trigger is important for the averaging technique; only
potentials that are time-locked to the trigger will be recorded
(Pease et al., 2007).7. Signal averaging and noise reduction
The widespread adoption of signal averaging in the 1970s has
greatly enhanced the precision of NCS, particularly those on sen-
sory nerves, where the signal-to-noise ratio is lower than duringmotor conduction studies. Prior to the advent of averaging, a com-
mon method for defining small potentials was to superimpose
multiple sweeps (as in Fig. 7B and the lowest traces in Fig. 8),
but this does not allow latencies to be measured precisely. In clin-
ical practice, signal averaging is indicated whenever there is a low
signal-to-noise ratio, i.e., when the background ‘‘noise” obscures
the potential to be recorded or the latencies of that potential.7.1. Sensory nerve action potentials and somatosensory evoked
potentials.
In these recordings, the signal may be so small that the noise
inherent in the recording obscures the potential (Fig. 7A). Sensory
nerve action potentials (SNAPs) may be recorded with surface elec-
trodes (or near-nerve needle electrodes (Buchthal and Rosenfalck,
1966)) but with both techniques the SNAP is often difficult to
define in single sweeps; somatosensory evoked potentials (SSEPs)
are always so. Signal averaging is recommended routinely, even
when the potential can be visualised readily, because it is critical
that onset latency be defined accurately. For example, in ortho-
dromic recordings the sensory potentials of the median and ulnar
nerves using surface electrodes may be some tens of lVs at the
Fig. 7. Averaging to define sensory nerve action potentials and muscle action potentials. A, a small sensory nerve action potential in response to weak stimulation of the index
finger (at 11.3 mA) recorded using surface electrodes over the median nerve at the wrist. Eight successive single responses, with an indefinite response peaking at ~3 ms
(vertical dotted line). A clearer potential with an onset latency of 2.5 ms is apparent when 9 sweeps were averaged (vertical arrow). B, raster display of EMG activity during
voluntary abduction of the thumb, with an uncertain potential, no bigger than the background EMG activity, at the vertical dotted line. Lowest trace:superimposition of the
rastered traces at higher amplification, showing a consistent waveform, the H reflex, at the vertical arrow. Note the absence of a direct motor response (M wave) at this
stimulus intensity (5.4 mA). To define the reflex latency would require signal averaging (not illustrated).
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and axilla, because the sensory volley becomes increasingly dis-
persed the greater the distance. Dispersion with distance is greaterFig. 8. Improvement in the signal-to-noise ratio. Sixteen raw evoked potential
responses are cascaded on the left, and averaged two by two in the second column,
then successively to the right averages of 4, 8 and all 16 traces. The raw and
averaged traces are superimposed in the bottom row. The potential is not clear in
the raw sweeps but becomes clearer as more sweeps are averaged. From Stegeman
and Van Putten (2017), with permission.for SNAPs than for CMAPs because of the duration of the unitary
potentials that summate to give the compound response (1–2 ms
for axonal potentials; 10–15 ms for EMG potentials), such that
there is greater phase cancellation for the SNAP. When recorded
from Erb’s point, the sensory potentials will be much smaller than
when recorded in the upper limb, and the traces are more likely to
be contaminated by EMG activity. In pathology, the SNAP may be
difficult to identify in a single sweep, such that the signal-to-
noise ratio is poor even in distal recordings.
The ‘‘reference” electrode used for SSEPs should be chosen so
that activity detected by the reference does not distort the activity
recorded by the ‘‘active” electrode. For upper-limb nerves, many
laboratories use a cephalic reference at Fpz but this injects frontal
activity into the recording and should be discouraged. Less prob-
lematic cephalic reference sites are either the contralateral side
or the contralateral earlobe. A remote non-cephalic reference
allows far-field potentials generated by peripheral and deep mid-
line generators to be identified, but this is at the expense of greater
noise. The contralateral reference will effectively remove these far-
field potentials, so that the activity from the relevant sensory cor-
tex can be visualised. With lower limb nerves, there is little frontal
activity at Fpz and a reference at this site is satisfactory.7.2. EMG potentials
Not all noise is ‘‘machine noise”; it may be biological, and it may
even be necessary for the desired activity to appear (as in Fig. 7B).
Evoked EMG potentials commonly require averaging for accurate
definition when recorded during a voluntary contraction of the tar-
get muscle, e.g., when recording the motor evoked potential during
a background voluntary contraction of the target muscle (e.g.,
(Rossini et al., 2015)), or when recording the H reflex from amuscle
from which it cannot normally be recorded at rest (such as tibialis
anterior, the thenar muscles, extensor carpi radialis; see (Burke,
2016). In Fig. 7B, the background ‘‘noise” is the voluntary EMG
activity against which the H wave must be identified. Superimpos-
ing multiple sweeps may then allow the definition of the target
252 H. Tankisi et al. / Clinical Neurophysiology 131 (2020) 243–258potential (Fig. 7B), which can then be defined better by averaging
multiple sweeps (not illustrated).
Defining single MUPs in needle EMG studies is best done by
triggering from the MUP, delaying the display so that the main
component of the potential is at or just before the centre of the
trace (so that consistent late components can be identified), and
superimposing individual sweeps. Of necessity, only weak contrac-
tions can be studied, only low-threshold units can be defined, and
then only the largest of the active motor unit potentials (unless
window triggers are used). It is undesirable to average single motor
unit waveforms because components can be averaged out if they
are unstable and have a variable latency after the trigger compo-
nent of the motor unit. This usage will not be considered further.
7.3. EEG activity
In most clinical indications, the activity of interest is produced
by a trigger stimulus (e.g., an electrical stimulus), and therefore
occurs after the trigger, much as when recording SSEPs. However,
digitizing and storing the signal in a buffer allows access to activity
that precedes the trigger, in addition to that which follows it. With
electrical stimuli delivered by the computer, averaging pre-trigger
activity allows one to define a clear baseline uncontaminated by
the stimulus artefact and early components of the response. When
the stimulus is external, the timing of the trigger is not known with
certainty, and there needs to be continuous sampling of the activ-
ity to be averaged. This is the situation with cortical event-related
potentials, such as the Bereitschaftspotential, with which the trig-
ger signal is the EMG activity produced by a voluntary movement.
Averaging the activity that precedes the EMG trigger allows insight
into the cortical processes underlying the voluntary movement
(Shibasaki and Hallett, 2006). Similarly, ‘‘jerk-locked back-
averaging” may allow the definition of spike activity in the EEG
prior to myoclonic jerks (Shibasaki and Hallett, 2005).
7.4. Practical issues when averaging signals
In the averaging process, the recorded trace is averaged against
the stimulus that evoked the activity. In diagnostic studies, this is
usually electrical. Activity evoked by the stimulus will be tightly
synchronized to it, and gradually emerge from the background
noise, as the noise averages towards zero because it is not locked
to the stimulus (Fig. 7, 8). However, if the major source of noise
is mains interference at 50 Hz or 60 Hz, problems can occur if the
stimulus is delivered at a sub-harmonic of these frequencies
because averaging would then enhance the mains interference
rather than reduce it. This problem is avoided by delivering stimuli
at a rate slightly off subharmonics of the mains frequency – per-
haps 4.1 or 5.1 Hz for the upper limb SSEPs during intraoperative
studies. It then takes about 1 min to produce the required number
of sweeps to be certain that a change in the SSEP is genuine. At
these rates, there is only a small effect on the early SSEP compo-
nents. The use of notch filters to minimize the mains interference
is acceptable only if there is little or no energy at 50–60 Hz in
the response being averaged.
For NCS, there is no fixed number of trials to be averaged for any
one indication: the number varies with the signal-to-noise ratio. It
is recommended that averaging is not be stopped automatically
when some arbitrary number is reached, because there may be
too few sweeps in the average to define small potentials. Instead
multiple averages should be made using as many traces as required
to define the potential. These averages can be superimposed to
confirm small potentials and then summated into a single grand
average (Fig. 8), avoiding any individual average that is contami-
nated by artefact. Many practitioners turn off the sweep limit in
the program (or increase it to, e.g., 9999).For intraoperative monitoring, particularly of SSEPs, ‘‘continu-
ous averaging” can be employed without the need to stop averag-
ing after a defined number of sweeps and start again from zero. As
new traces are added, older traces are discarded from the moving
average (Sgro et al., 1989). In a further refinement, the weighting
of the traces in the displayed average can be adjusted so that the
most recent traces have a greater influence on the displayed wave-
form than older traces, a process that provides an exponentially
weighted moving average. With this weighting, once the preset
count has been reached, the exponential average is continuously
updated and looks like a running average, except that the more
recent data have a greater influence on the displayed average. This
allows more rapid identification of deterioration in the SSEP.
The artefact reject facility may be useful when recording SNAPs
and SSEPs. Using artefact rejection, when the input exceeds a spec-
ified voltage the trace is considered to be too contaminated by
artefact, and it is not included in the average. This can occur due
to inadvertent movement, EMG contamination or a decaying stim-
ulus artefact. In the latter case, the rejection can be set to occur
after the artefact has decayed sufficiently.
To define a small target potential against the background noise,
separate averages are preferable to a single average of all responses
because a genuine response should be reproducible in different
averages. Doubling the number of traces in an average does not
double the signal-to-noise ratio: it improves it by only the square
root of 2, i.e., by 1.4. Visual inspection of superimposed shorter
averages may define a waveform better than a single long average,
and the separate averages can then be combined into a single
grand average, perhaps omitting those contaminated by artefact
(Fig. 8).
It is crucial that both the current trace and the updated average
be displayed simultaneously. This allows the examiner to identify
artefacts affecting only single trials, and either to reject those trials
from the average or to reject the average and start again.
Averaging will only define accurately activity that is tightly syn-
chronized to the stimulus, unless the recorded traces are full-wave
rectified. This is the reason why unstable MUPs may be difficult to
define accurately in qEMG. With reflex activity, only the short-
latency reflex (H reflex) can be defined clearly in unrectified traces,
and the long-latency reflex activity is less-well defined, both in
latency and size because it is polysynaptic, and there is then
greater latency variability. Similarly, F waves cannot be defined
by averaging raw traces because each F wave has a slightly differ-
ent morphology and latency (Fig. 9A and B) so that phase
cancellation affects the average – unless the traces are full-wave
rectified before averaging (Fig. 9C). If this is done, it is imperative
that the rectified trace has returned to baseline before the target
activity appears, and a 100-Hz high-pass filter may then be
desirable.
8. Electrodes
Standard electrophysiological recordings require the use of a
minimum of two electrodes since all such recordings are differen-
tial—meaning that the signal measured at the first is compared to
that obtained at the second. In so-called ‘‘unipolar” or ‘‘referential”
recordings, one electrode is in close proximity to the active fibres
or fibres of interest (the active electrode (E1)) and the second is
placed at a distance in a region expected to receive minimal contri-
bution from the active fibres (the reference electrode (E2)). In so-
called ‘‘bipolar” recordings, the two electrodes are placed in rela-
tive close proximity to the active fibres. Whereas unipolar/referen-
tial recordings assume that the recording area is electrically silent,
in some situations, most notably when recording certain surface
motor responses (e.g., ulnar or tibial motor responses), this refer-
ence electrode also senses substantial volume-conducted electrical
Fig. 9. Averaging F waves of the thenar muscles. A, superimposed sweeps (n = 20). B, raster display of the 20 sweeps, at lower gain, showing variability of the morphology and
latency of the F waves in consecutive traces. This renders averaging the raw EMG traces invalid. C, average of full-wave rectified traces recorded using a high-pass filter of
100 Hz. A and B are reproduced from Fig. 1.10 in Pierrot-Deseilligny and Burke (2005), and C from Fig. 3 in Espiritu et al. (2003), with permission.
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employed (see Section 2.1.1 ‘‘Amplifiers” for further explanation).
More recently, electrical impedance methods have also been
introduced into the field of neuromuscular medicine (Sanchez
and Rutkove, 2017). Electrical impedance methods typically
require a minimum of four electrodes to reduce electrode contact
impedance, two for applying an external electrical current through
the tissue and two other electrodes for measuring the resulting
voltage. Since the electrical current applied is high frequency
(e.g., 50 kHz), it does not excite tissues, there are no bioelectrical
signals being generated, and so the electrodes are not referred as
‘‘active” or ‘‘reference” electrodes—rather both current and voltage
electrodes assess the region of tissue beneath and between them.
The details of this method are beyond the scope of the present rec-
ommendations and have been discussed in detail in a separate
IFCN guidelines ‘‘Standards for Quantification of EMG and Neurog-
raphy” (Stålberg et al., 2019).
8.1. Electrode materials and other considerations
Materials commonly used in electrodes include: platinum,
stainless steel and silver-silver chloride. Most surface electrodes
require a conductive medium to ensure good electrical contact
with the skin; this may consist of electrode jelly/paste, saline, or
an adhesive gel. Whenever possible identical materials should be
used for the electrodes to help reduce electrode contact impedance
mismatch which could deteriorate the signal-to-noise ratio. The
contact impedance between tissue and the electrode can be mod-
elled as a circuit with a capacitance and resistance in parallel,
resulting from the electrode surface, the electrolytes, and the tis-
sue. The contact impedance increases as the electrode area
decreases and decreases with increasing frequency. The single-
electrode impedance can vary from one to several hundred kX.
The contact of a metal with an electrolyte (electrode paste/jelly
or the tissue itself) creates an electrical potential difference
between 100 and 600 mV called the electrode polarization poten-
tial. Movement of an electrode within the tissue may change elec-
trolyte concentration locally and thereby create changes in
galvanic cell voltage for a short period of time, and is the likely
cause of movement artefacts. At rest, this potential does not con-
tribute to the observed values.
8.2. Needles
In standard electromyography (EMG), a concentric needle (i.e.,
comprising an outer cannula [reference electrode] and inner core
[active electrode]) is usually preferred although monopolar nee-
dles (i.e., the cone tip of the needle serves as single electrode)can be used as well. As the recording surface of both of these nee-
dles is large relative to the diameter of individual muscle fibres,
they record from the cumulative activity of many muscle fibres
of a motor unit. The MUP itself represents a summation of the elec-
trical activity of a number of muscle fibres belonging to the same
motor unit.
The concentric needle consists of two electrodes, the first elec-
trode is a wire electrode, typically platinum that is insulated and
housed within a steel cannula acting as the second electrode. The
surface area of the wire electrode depends on the wire diameter
and the bevel angle of the needle and is usually between 0.01
and 0.09 mm2, typically 0.07 mm2. The differential recording is
then achieved by measuring the voltage between the wire elec-
trode (active electrode (E1)) and the entire cannula shaft (reference
electrode (E2)). The main spike component of the MUP is generated
by approximately 2–12 fibres within a radius of about 0.5–1 mm
around the tip of the needle. More distant fibres contribute to
the initial and late parts of the potential. Due to the short distance
between the electrodes, a great commonmode voltage recorded by
the active and reference electrodes is present leading to the elim-
ination of much distant activity and providing a relatively sharp
and self-contained MUP.
Monopolar needles for EMG recordings are usually constructed
from a stainless-steel core that is coated with Teflon except for an
exposed cone tip of 1–5 mm that acts as the active electrode. The
recording area is approximately 0.03–0.34 mm2. The potential dif-
ference is measured between the exposed tip of the needle and a
second reference electrode. This reference electrode may be a nee-
dle placed subcutaneously or a surface electrode at some distance
from the active electrode. The reference electrode should be placed
over an electrically silent area, such as a tendon or a bone. Impe-
dance mismatch between the active monopolar needle and a sur-
face electrode can lead to a reduced common-mode signal and
greater artefacts, including power line interference (50 or 60 Hz).
Monopolar needles record larger amplitudes and greater duration
than concentric needles, but the number of phases is comparable.
Monopolar needles can also be used as recording electrodes for
sensory nerve action potentials in the near-nerve technique (Kural
et al., 2017) and as stimulation electrodes (e.g., stimulated single-
fibre EMG) (Kouyoumdjian and Stålberg, 2008). In the former situ-
ation, the reference electrode is also usually a monopolar needle
placed subcutaneously at a distance from the nerve. Hollow core
monopolar needles are also used for botulinum toxin injection,
assisting with correct muscle localization prior to injection.
Single fibre EMG electrodes have an active region consisting of a
platinum wire approximately 25 mm in diameter exposed on a side
port of a steel cannula, with the cannula itself serving as the refer-
ence lead (similar to a concentric needle). Within the pick-up range
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healthy muscles there are usually no more than 2–3 fibres, allow-
ing for pairs of fibres to be easily obtained. Concentric needles can
also be used to collect ‘‘single-fibre-like” data; this is achieved by
increasing the cutoff frequency of the high pass filter so as to help
distinguish individual spikes within the MUP.
There are a variety of other less commonly used needles
designed for specific applications. For example, in microneurogra-
phy insulated tungsten electrodes, exposed for 5–10 mm at the nee-
dle tip, are used. Bipolar and multipolar needle electrodes’
configurations are also used for MUP analysis during strong effort,
volume conduction studies, assessing the muscle fibre conduction
velocity, or evaluating the territory of a motor unit. One additional
unusual needle is that used for macro-EMG. This can be thought of
as a combination single fibre-monopolar electrode. The side port
electrode is used only to trigger recording and the actual potential
is recorded between the exposed tip and remote reference elec-
trode (subcutaneous or surface). A final class of needles include
those that can be used for electrical impedance myography, either
alone or in combination with standard monopolar EMG electrode
(Kwon et al., 2018). An impedance-EMG needle may have 4-
impedance electrodes around an insulated shaft of the needle with
a 5th electrode, the exposed tip, serving as the monopolar (active)
EMG electrode.
Due to the risk of transmission of infectious diseases (e.g. hep-
atitis, human immunodeficiency virus, prion disease), disposable
needles are used in all circumstances. Given this and the expense
of single-fibre EMG electrodes, many laboratories choose to mea-
sure ‘‘jitter” using concentric needle electrodes designed for facial
EMG (e.g., diameter 0.3 mm, recording area 0.02 mm2) and a more
restricted bandpass (1 kHz to 10 kHz) (Kouyoumdjian and Stålberg,
2008; Kokubun et al., 2012).
8.3. Surface electrodes
Surface electrodes are used as stimulating or recording elec-
trodes for NCS, for recording surface EMG data, for serving as ref-
erence electrodes for monopolar needle EMG, and as a common
reference or ‘‘ground” electrode. In the past, surface electrodes
generally consisted of small round or square reusable metal disks
or metallic wire loops (the last for use in measuring sensory poten-
tials from the digits), all employed in conjunction with a conduc-
tive electrode gel. However, to reduce the risk of infection and
for reasons of convenience, this approach has been increasingly
replaced with the use of self-adhesive, disposable electrodes. These
are generally silver-silver chloride electrodes, with an adhesive
conductive gel overlying the electrode surface; they can often be
used several times on a single patient before they need to be
replaced, generally because the adhesive loses its efficacy. Reusa-
ble, saline-saturated Velcro fabric band electrodes are also used
to record sensory potentials from the digits. For surface recordings
of electrical impedance myography, both reusable metal and dis-
posable carbon-based electrodes have been used. Electrical impe-
dance myography has been discussed in detail in a separate IFCN
guidelines ‘‘Standards for Quantification of EMG and Neurography”
(Stålberg et al., 2019).
A variety of surface stimulating electrodes are used for nerve
conduction studies. Most commonly these include metal ‘‘prong”
electrodes used with a small amount of adhesive gel or saline-
soaked felt electrode pads or pledgets. In either case, the electrodes
are embedded within a handheld stimulator that can be easily
repositioned to help identify the best region for stimulation. Small
metal disk or adhesive electrodes, described above for recording,
can also be used for stimulation, especially if repeated recordings
from a single nerve are desired over an extended period of time.
This is the case, for example, when performing studies of nerveexcitability (including measurements of strength-duration time
constant, threshold electrotonus and recovery cycle). The details
of excitability techniques are beyond the scope of the present rec-
ommendations and have been discussed in detail in a separate
IFCN guidelines ‘‘Measurement of axonal excitability”.
Although surface electrodes are widely used for NCS, conven-
tional surface EMG methods consisting one bipolar signal from
two electrodes cannot provide detailed information about motor
unit morphology, including their distribution across the muscle
endplate. Therefore, special multi-channel high density surface
EMG (HD-sEMG) techniques have been developed. HD-sEMG
requires sophisticated instrumentation and signal analysis of mea-
sures from multiple closely spaced electrodes, overlying a
restricted area of the muscle. This enables measurement of both
temporal and spatial EMG activity, thus providing different aspects
of motor unit characteristics, such as muscle fibre conduction
velocity measurements, motor unit number estimation and the
evaluation of single motor unit characteristics. HD-sEMG has been
shown to be beneficial for the assessment of different clinical con-
ditions including motor neuron disorders (Wood et al., 2001; Drost
et al., 2004) and disorders (Huppertz et al., 1997) and pathological
changes have been shown at the motor unit level in neurogenic
and myopathic muscles. However, HD-sEMG has not yet been
incorporated into clinical practice as a diagnostic tool. Recent
research has also mostly focused on physiological studies
(Sleutjes et al., 2018; Lapatki et al., 2019), sports medicine
(Martinez-Valdes et al., 2017) and rehabilitation (Gallina et al.,
2016) rather than the primary diagnosis of neuromuscular disor-
ders. Detection of the HD-sEMG signals requires high quality
amplifiers with suitable specifications. Several kinds of amplifica-
tion chains have been described for different strategies. As HD-
sEMG remains a research method, further details of these tech-
niques are beyond the scope of the present report.9. Stimulation
For nerve conduction studies, repetitive nerve stimulation test,
stimulated single fibre EMG, and nerve excitability testing, an elec-
trical stimulus is delivered to the nerve. Standard stimulation tech-
niques use surface electrodes, whereas needle electrodes are used
for nerve root stimulation or deep nerve stimulation (e.g., the sci-
atic nerve). Usually two surface electrodes are placed over the nerve
with an inter-electrode distance of 2–4 cmwith the cathode (where
the nerve is stimulated and membrane depolarisation occurs)
placed closest to the recording electrode. Inversion of the polarity
of the stimulation electrode will affect the point of stimulation,
and thereby the onset latency and nerve conduction velocity.
With deep nerves, a short interelectrode distance should be
avoided because a greater stimulus is required the deeper the
nerve and, it is then more painful. This may be an issue when stim-
ulating the radial nerve in the spiral groove or the femoral nerve.
The duration of the stimulus is usually between 0.1 ms and
1.0 ms. The activation time of axons varies with the duration of
the stimulus, even when it is supramaximal, and the measured
latency includes this time. In routine nerve conduction studies,
short duration stimulus pulses are therefore preferred, and this
also (1) minimises patient discomfort, (2) restricts the site of stim-
ulation which may spread with longer duration pulses, as well as
high intensity pulses, and (3) reduces the stimulus artefact. In H-
reflex studies, a longer stimulus duration (1.0 ms) is used to favour
the activation of the large sensory fibres (Ia afferents) responsible
for the reflex. The stimulus can be applied as single pulses, paired
pulses, or as trains with repetition frequencies between 1–2/s and
50/s for repetitive nerve stimulation test. High-frequency stimula-
tion (20–30 Hz for 1–2 s) has been used for detection of incremen-
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recently a single shock before and after a brief maximum voluntary
contraction is preferred to demonstrate increment because this
reduces discomfort and is equally effective.
Two types of stimulators are used. The constant voltage stimu-
lator delivers a constant voltage (0 V to 400 V). The disadvantage of
this type is that the resultant current is not constant because of the
fluctuations of the electrode-tissue impedance. Constant current
stimulators deliver a constant and stable current (0 mA–100 mA).
Stimulus current is independent of electrode/skin impedance as
long as the stimulator is not overloaded. Constant current stimula-
tion is therefore preferred by most physicians.
Supramaximal stimulation is required in standard nerve con-
duction studies and repetitive nerve stimulation test to activate
all axons at the same time for measurement of motor and sensory
response amplitudes, and nerve conduction velocity. Particularly
when stimulating at proximal sites (e.g., Erb’s point) or in nerves
with very high threshold due to pathology (demyelination, nerve
hypertrophy), it may be difficult to reach a supramaximal level.
The most proximal parts of peripheral nerves can be activated by
TMS or high-voltage electrical stimulation over the spine, provid-
ing additional information to that from peripheral NCS
(Matsumoto et al., 2010). Conduction across proximal segments
of peripheral nerves, plexuses and nerve roots is commonly tested
using H-reflexes and F-waves. An alternative technique using mag-
netic stimulation or high-voltage electric stimulation involves
direct stimulation of the nerve roots, and this may be preferable.
Conversely too-high stimulus currents will result in both distal dis-
placement of the stimulation site, leading to a shorter onset
latency, and stimulation of nearby nerves. Avoiding a stimulus that
is too high is important to ensure the most information with the
least discomfort or pain. However, this must be tempered by the
fact that erroneous reports of conduction block occur when the
stimulus was not really supramaximal, particularly when stimulat-
ing at proximal sites. If a supramaximal stimulus causes discomfort
that is regrettable but preferable to an erroneous conclusion.
10. Artefacts
The goal of the recording system is the exact reproduction of
the physiological signals generated in muscle cells and peripheral
nerves, but artefacts are unavoidable (Webster, 1984). They can
have a technical or a biological origin (Amrutha and Arul, 2017).
The most frequent cause of artefact is the electromagnetic radia-
tion from power sources of 50 or 60 Hz, since its frequency is
within the physiological range of the EMG signal. However, the
neurophysiologist should know other possible causes.
Technical origin
a. Cable motion artefact, with possible additional triboelectric
(electrostatic) effect (low frequency range, 1–10 Hz) (Klijn
and Kloprogge, 1974).
b. Transducer noise from displacements in the gel-skin inter-
face, including changes associated with skin stretch
(Webster, 1984).
c. High electrode skin-electrode impedance (Basmajian and De
Luca, 1985).
d. Intrinsic noise from the EMG machine (e.g. from amplifiers
semiconductors).
e. Biomedical devices (e.g. pacemaker)
Biological origin
a. ECG
b. Neighbouring muscles (crosstalk)It is important to consider a number of procedures to reduce the
impact of artefact on the quality of the recording.
Isolate electrical circuit of the EMG machine from the ones for
other electrical devices, unplug and disconnect unnecessary
electrical devices and lights located in the room (Bischoff
et al., 1999), avoid use of fluorescent lights and dimmer
switches (they give high frequency noise spikes).
For conduction studies and surface EMG, skin surface should be
cleaned using sand paper, abrasive gel or 70% alcohol to reduce
skin impedance by removing electrically non-conducting ele-
ments forming a high-impedance transcutaneous potential gen-
erator, which is increased by stretch-deformation (Edelberg,
1973; Türker, 1993). Skin abrasion with or without a drop of
peeling paste is generally effective (Tam and Webster, 1977)
and although puncturing the skin with a needle has been pro-
posed as a well-tolerated option (Burbank and Webster,
1978), this is often not necessary.
Select the appropriate electrode size and their distance accord-
ing the muscle volume to reduce the chance of cross-talk. It
should be considered that smaller surface electrodes have
higher impedance, requiring more careful skin preparation.
Double differential recording can be used to eliminate cross-
talk in demanding protocols, in the latter technique signals
arriving simultaneously at both electrodes are deleted, since
propagating signals are time-delayed (De Luca and Merletti,
1988).
Filtering the signal to remove frequencies outside the known
physiological source is important (like mechanical and electri-
cal noise). However, elimination is not complete for the fre-
quencies above and below the setting limits. Filtering is not
useful for cross-talk, since desired and cross talk signals have
similar frequency ranges (Türker, 1993).
Proper patient grounding is essential to reduce electromagnetic
noise. The patient ground electrode is attached to the amplifier
as a reference to differential inputs to improve rejection ratio
mode. A large surface ground electrode or felt band ground
electrode is recommended, positioned close to the recording
electrode (between stimulator and recording electrode in con-
duction studies), not overlying electrically active surfaces like
as muscle, and with a low electrical resistance (<3–5 kOhms)
(Türker, 1993; McGill et al., 1982). Sometimes it is advisable
to ground the examiner too, in order to reduce power line arte-
fact. Make sure the power outlet used for the electrodiagnostic
system (equipment grounding) has good connection to ‘earth’
(i.e. to a pole buried in the earth outside the building). This is
also required for safe operation of the instrument.
Cables should be short, fixed, shielded, and separated from
others (in particular recording and stimulator cables).
Stimulus artefacts depend on its intensity, duration and dis-
tance between recording and stimulation sites. They can distort
the waveform and interfere with the accurate measurement of
latency with short nerve segments. As always, it is recom-
mended that the lowest supramaximal intensity is used.
Ideally, EMG should be performed in a quiet, temperature-
controlled room, separated from any source of electrical noise.
Screening of the rooms is not necessary anymore due to better
amplifiers.
It should be considered that when the amplitude and/or decay
of the stimulus artefact is an issue, attention needs to be paid to
the grounding, skin perspiration, the orientation of the stimulating
and recording electrodes, the quality of the skin-electrode interface
and the high-pass filter, for instance, are the recording electrodes
dry? If attention to these factors does not fix the problem, the
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within the linear range of the amplifier and A/D converter. Remov-
ing artefacts may be even more difficult during electrophysiologi-
cal examinations in intensive care units. To minimise artefacts, all
unnecessary plugs should be removed.11. Safety in NCS and EMG
11.1. Electrical safety and leakage currents
There are certain agreed international standards on safety of
electrodiagnostic equipment. For example, the maximum current
which leaks to ground is dependent on the type of the medical
devices but usually it should not exceed 10 mA at 50 Hz according
to IEC 60601–1 (International Electrotechnical Commission 2005)
recommendations (IEC, 2005). This leakage current should be mea-
sured by a biomedical engineer or technician and a proper ground-
ing provided. Some authorities mandate that equipment be
checked annually and a certification plaque be fixed to the EMG
machine. All ground sockets in the laboratory should be connected
to a single installation ground lead point. Ideally, all other electrical
devises including heating lamps must also be connected to this
point. No other ground terminals should be used (e.g. water pipes).
Although, the electrical currents used in NCS are too small to
damage the skin or underlying tissues, the heart is a sensitive
organ to any strong current across it. A small amount of current
may leak from the internal electronics when the electrical medical
devices are connected to the patient. This small current leakage is
often without any danger but there are certain conditions that this
current may be dangerously enhanced, for example, by stray cur-
rents in power cords, which correlates to the length of the cords,
for example with extension cords (AAEM, 1999). In normal condi-
tions, the 3rd prong on an electrical plug serves as a ground. This
enables dissolving the leakage currents on a power cord safely,
but in case of a malfunctioning ground, the leakage current may
induce arrhythmia while passing across the patient́s body. This
may happen if the ground electrode is placed on the contralateral
side to the stimulating electrode although this is more a theoretical
risk rather than an established risk (London, 2017). To avoid this;
(1) the ground electrode should never be placed contralaterally
to the stimulation site and (2) extension cords should not be used.
Special attention should be paid in intensive care units where the
patients are connected to several electrical medical devices.11.2. Implanted pacemakers, cardiac defibrillators and stimulators
Pacemakers are used to treat bradycardic episodes while intrac-
ardiac defibrillators treat tachycardic events such as ventricular
fibrillation. Both function as sensing and stimulating devices, and
most electromyographers are concerned that these devices may
be charged improperly during NCS. Existing studies showed that
pacemakers or intracardiac defibrillators cannot sense NCS stimu-
lations including supraclavicular stimulations even by using stim-
ulus intensities and durations that probably exceed those routinely
used (LaBan et al., 1988; Schoeck et al., 2007; Cronin et al., 2013).
The only risk may arise in patients with old pacemakers with
monopolar sensing configurations in case high intensity proximal
repetitive stimulation is used. This may alter the pacing for 2–3
seconds which will in fact not cause more than lightheadedness
in these patients (London, 2017). Some pacemaker or automatic
implantable cardioverter-defibrillator companies require the
placement of a ‘‘magnet” on the devices to monitor heart rhythm
during NCS. However, an earlier study showed that magnet-
placed patients reported more symptoms so this is not recom-
mended during NCS (Ohira et al., 2013). While modern pacemakerswith bipolar configuration and automatic implantable
cardioverter-defibrillators implanted below the skin are shown to
be safe, NCS are still contraindicated in patients with temporary
transvenous cardiac pacemakers because they may have a direct
electrical conduit from the surface of the skin to the heart
(London, 2017). Peripheral intravenous lines in extremities are safe
but for the safety of central venous catheters, further research is
necessary. Some authors have suggested in these patients that
proximal NCS or NCS in the ipsilateral extremity should not be per-
formed because the catheters in the internal jugular or subclavian
veins extend to the heart (Al-Shekhlee et al., 2003) while others did
not show any influence of NCS on electrocardiographic monitoring
(London, 2017). No interaction was found between NCS and deep
brain stimulator devices (London, 2017). It is suggested that cau-
tion should be excised in this area.11.3. Recommendations on electrodiagnostic studies and
anticoagulation
In a recent review, no precautions were recommended during
needle EMG examinations in patients on warfarin therapy if
INR < 3.0 or on antiplatelet medication (London, 2017). If the
INR > 3, the studies may be performed at the discretion of the
examiner. In both conditions, close surveillance during and imme-
diately after the examination is essential. There is no literature on
the risks of heparin or other oral anticoagulant therapy, but pre-
cautions are likely to be unnecessary at therapeutic doses. How-
ever, a recent survey showed that some electromyographers are
as cautious as with warfarin about the novel (direct) oral anticoag-
ulants, particularly for EMG of the paraspinal and facial muscles
and single fibre EMG (Lee and Kushlaf, 2018). Prospective risk–
benefit studies are necessary to establish safety guidelines.12. Storage of data and databases
Following the developments in computer technology over the
last decades, storage of data is far easier. This has led to more data
being recorded and so available for review, and comparison within
and between departments. EMG machines store data in different
ways; raw signals stored during recording and then reanalyzed
when numerical information is needed, or a combination of signals
and numerical data that results from algorithms. However, the
large increase in data storage is expensive, requires external hard
disks or servers, and raises issues about confidentiality. Data are
typically copied to the data storage facility of the hospital to allow
reliable long-term storage and retrieval.
EMG reports and data should have common EMG terminologies
and dataset structures (Johnsen et al., 1994). Telecommunication
between laboratories based on these standards would enable
exchange of EMG data between laboratories, for consulting, and
research on multicentre databases e.g., the international multicen-
ter ESTEEM project (Pugdahl et al., 2017). ESTEEM is a quality
development project which has been going on since 1992, and
the extensive data collection built up a multicentre EMG database
with more than 1000 cases being used for medical audit studies
and development of standards and guidelines for EMG practice.
Depending on local security legal aspects, coded diagnostic
labels and photos or films may be included with NCS/EMG data.
Thus far, manufacturers and different hospitals specialties and
nations have not agreed common data protocols for storage,
though there are current initiatives on this. One way, not yet used
widely, is to use intermediate software to retrieve data from any
database and transform these to a common agreed standard that
allows more widespread accessibility with necessary security.
While necessary, this is likely to prove arduous.
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tive EMG and other methods, there is an obvious need for data-
bases for automatic calculation of deviation from normal,
reporting, archive functions, scientific or pure clinical statistical
summaries. Many EMG labs now have tens of thousands of
patients in databases which are assisting the refinement of electro-
diagnosis. As yet, just as there is no international standard for stor-
age, retrieval and exchange of data, there is no standard for data
formats, databases and report generators in EMG/NCS. However,
the above-mentioned ESTEEM project aims to establish these,
and recently an IFCN committee has been constituted to consider
a standard format, so that data can be shared among investigators
and analyzed on any machine. With a standard format it is possible
to build large databases for educational purposes, research on rare
disorders, quality development within and between laboratories
and for expert consultation. With data mining on large databases
from different laboratories, it may be possible to develop artificial
intelligence or support systems to assists the examiner in the
examination strategy and diagnoses of neuromuscular disorders,
now more obtainable than 25 years ago (Vingtoft et al., 1993).13. Report generators
There are no agreed standards for report generation. General
principles have been formulated, but content and layout vary con-
siderable from one EMG lab to the other (Johnson, 1988; Stålberg
et al., 1991). A report generally, contains:
 Patient ID data
 Previous and recent medical history; usually a summary of
referring request
 The results of a short neurological examination
 Preliminary strategy
 NCS/EMG results, with narrative information, numerical data in
tables with sometimes, graphs showing reference limits
 An interpretation of the NCS and EMG
 Other electrodiagnostic parameters
 A general conclusion with the electrodiagnostic findings placed
in a context of the patient’s presenting complaint. It is para-
mount that neurophysiological findings relevant and those not
relevant to the patient’s problem are distinguished. For instance
sometimes a mild carpal tunnel syndrome may be irrelevant to
someone with a more severe and symptomatic radiculopathy.
 Some laboratories also enclose various signals, other do not but
display them on regular rounds (Stålberg et al., 1991). Data in
the report can either be imported directly from the EMG
machine after editing or produced later from the database.
14. External communication
Remote internet connections for external communication are
widely used such as servers within hospitals for storage and
administrative functions and for consultations and remote inter-
pretations. Here HL7 standard is recommended. Regional and
national interactions are becoming more common and are facili-
tated by standardization. The transfer of text, signals and video
has become more frequent in clinical neurophysiology (Stålberg
and Stålberg, 1998; Jabre et al., 2000; Stålberg, 2002) though no
standards have evolved. The platforms for such data communica-
tion include:
Local Area Networks (LAN): between local equipment, office
stations, local server, and between the laboratory network and
hospital administrative networks.
Wide Area Networks (WAN): between satellite and central lab-
oratories or to outside laboratories for bilateral consultations. Forany communication, local hospital regulations on security and data
integrity must be followed. A safe and encrypted VPN connection is
recommended for external communication. For an even higher
degree of safety, MPLS-VPN may be considered. Live testing of
video conference programs is recommended to ensure correct
functionality, since some programs are blocked by hospitals for
security reasons. For service and educational purposes, it may be
useful to have a Remote Support program installed in the EMG
machine, is installed which allows a remote trusted user to adjust
settings or give advice in critical situations
15. Concluding remarks
EMGmachines are now highly sophisticated, and serve not only
the performance of tests but also report generation and data stor-
age. To obtain optimal return on the investment in a new machine,
the clinical neurophysiologist must understand its workings, be
fully aware the effects of different electrodes and different stimu-
lus and recording parameters, and be able to personalize the com-
puter programs. As data accumulates, the EMG machine will
become increasingly able to ”suggest” the next appropriate steps
in an examination and the final diagnosis.
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